Lumexa Q1 rev $252.5M (+3.1%); net income $1.7M vs loss; reaffirms FY guidance

Lumexa Imaging Holdings, Inc.

2026-Q1 EPS reported $0.02 vs consensus $0.12 ▼ miss (-83.9%)

Consolidated revenues of $252.5M, up 3.1% YoY; net income $1.7M vs net loss of $7.7M.
GAAP EPS $0.02; Adjusted EPS $0.18; Adjusted EBITDA $51.2M (20.3% margin) vs $51.0M.
Same-center advanced volume growth of 5.6% for both consolidated and system-wide.
Announced four new centers: two tuck-in acquisitions and two de novos; on track for 8-10 de novos in 2026.
FY 2026 guidance reaffirmed: rev $1.045-1.097B, Adj EBITDA $234-242M, Adj EPS $0.71-0.77.

item 2.02 item 7.01 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.98

Lumexa Imaging Holdings, Inc. reported the first quarter ended March 31, 2026 results: revenue $252.5 million, net income $1.7 million, EPS $0.02 per share. Guidance reaffirmed.

Period: the first quarter ended March 31, 2026
Revenue: $252.5 million
Net income: $1.7 million
EPS: $0.02 per share
Guidance: reaffirmed
Result: reported results

Exact text from the filing

for patients, providers, and payors.” First Quarter 2026 Highlights: All comparisons are to the quarter ended March 31, 2025, unless otherwise noted • Consolidated revenues of $252.5 million, an increase of 3.1% from $245.0 million • System-wide revenue growth of 4.0% • Same center advanced volume growth: 5.6% for both consolidated and system-wide • Net income of

View on SEC.gov

Browse all earnings releases →

Lumexa Imaging Holdings, Inc. filing history →

Source: SEC EDGAR

accession 0001193125-26-219415

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.